Cincinnati Epilepsy Center Again Designated Level 4

The Epilepsy Center at the UC Neuroscience Institute has again been designated a Level 4 Epilepsy Center—the highest level—by the National Association of Epilepsy Centers (NAEC). The center, directed by Michael Privitera, MD, a professor in the UC College of Medicine’s Department of Neurology and Rehabilitation Medicine, has held this designation consistently since 2005.

The NAEC is a nonprofit trade association with a membership of more than 170 epilepsy centers. The organization defines Level 4 epilepsy centers as "having the professional expertise and facilities to provide the highest level medical and surgical evaluation and treatment of patients with complex epilepsy.” The designation of Level 4 or the NAEC’s other level, Level 3, is made as a result of member centers’ responses to a self-designation survey.

"The Level 4 designation is only one indicator of our center's excellence," says David Ficker, MD, an associate professor in the Department of Neurology and Rehabilitation Medicine and medical director of the Epilepsy Monitoring Unit at UC Medical Center. "From expertise in the outpatient clinic to advanced epilepsy diagnostic testing and surgical treatment, our Epilepsy Center provides outstanding care for patients with epilepsy and seizures. No patient with epilepsy needs to leave the region to get expert care for their seizures.

The UC Neuroscience Institute is one of four institutes of the UC College of Medicine and UC Health. It includes 14 centers and programs.

Related Stories

1

UC students organize free health clinic happening July 11-12

July 10, 2026

The University of Cincinnati student chapter of Remote Area Medical is holding its annual free health clinic July 11-12. The clinic is open to adults and children, with no income requirements. Anyone in the area who needs medical, dental or vision care will have a chance to get it for free, with no insurance required.

2

Is speech-to-text AI really reliable?

July 10, 2026

UC researcher Nelly Elsayed’s study in the International Journal of Medical Informatics reveals key risks in clinical speech-to-text AI and shows why human review is essential.

3

Hoxworth Blood Center CEO advocates on Capitol Hill during National Blood Advocacy Week

July 9, 2026

Hoxworth Blood Center, University of Cincinnati, has announced that David Oh, MD, director and chief executive officer, joined blood center leaders, patient advocates and partner organizations in Washington, D.C., in June as part of Blood Advocacy Week, a national initiative led by America’s Blood Centers to strengthen the nation’s blood supply.